trial · primary record
INCA033989
Essential Thrombocythemia
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 426 |
| Primary completion | 2030-11-01 |
| Primary endpoint | Durable clinicohematologic response (DCR) |
| Registry ID | NCT07623200 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:33.108Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07623200
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Inca033989 · compound